立方制药：拟3400万元转让美沙拉秦肠溶片药品所有权
Hefei Lifeon Pharmaceutical (SZ:003020) Xin Lang Cai Jing·2025-12-30 11:39Group 1 - The company has signed a contract with Kew Flower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. for the transfer of ownership of Mesalazine Enteric-Coated Tablets [1] - The transfer price for the ownership of the drug is set at 34 million yuan [1]